Identification of flotillin-2, a major protein on lipid rafts, as a novel target of p53 family members

Molecular Cancer Research

Volumn 6, Issue 3, 2008, Pages 395-406

  Sasaki, Yasushi ^a   Oshima, Yuichiro ^a   Koyama, Ryota ^a   Maruyama, Reo ^a   Akashi, Hirofumi ^a   Mita, Hiroaki ^a   Toyota, Minoru ^a   Shinomura, Yasuhisa ^a   Imai, Kohzoh ^a   Tokino, Takashi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLOTILLIN 2; INTERLEUKIN 6; PROTEIN DERIVATIVE; PROTEIN P53; PROTEIN P63; PROTEIN P73; SMALL INTERFERING RNA; STAT3 PROTEIN; TAP63GAMMA PROTEIN; TAP73BETA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOSKELETON; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPID RAFT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

BLOTTING, NORTHERN; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

RODENTIA;

EID: 40949125116     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0108     Document Type: Article

References (60)

1. El-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 1998;8:345-57.
2. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
3. Tokino T, Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 2000;33:1-6.
4. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
5. Jost CA, Marin MC, Kaelin WG, Jr. p73 is a human p53-related protein that can induce apoptosis. Nature 1997;389:191-4.
6. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19.
7. Osada M, Ohba M, Kawahara C, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998;4:839-43.
8. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-16.
9. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-8.
10. Melino G, De Laurenzi V, Vousden KH. p73: friend or foe in tumorigenesis. Nat Rev Cancer 2002;2:605-15.
11. Yang A, Walker N, Bronson R, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000;404:99-103.
12. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-13.
13. Celli J, Duijf P, Hamel BC, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999;99:143-53.
14. Irwin MS, Kaelin WG. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 2001;12:337-49.
15. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002;18:90-5.
16. Yang A, McKeon F. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 2000;1:199-207.
17. Yu J, Zhang L, Hwang PM, et al. Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A 1999;96:14517-22.
18. Ueda Y, Hijikata M, Takagi S, et al. p73β, a variant of p73, enhances Wnt/ β-catenin signaling in Saos-2 cells. Biochem Biophys Res Commun 2001;283:327-33.
19. Zheng X, Chen X. Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family. FEBS Lett 2001;489:4-7.
20. Blint E, Phillips AC, Kozlov S, Stewart CL, Vousden KH. Induction of p57 (KIP2) expression by p73β. Proc Natl Acad Sci U S A 2002;99:3529-34.
21. Sasaki Y, Ishida S, Morimoto I, et al. The p53 family member genes are involved in the Notch signal pathway. J Biol Chem 2002;277:719-24.
22. Fontemaggi G, Kela I, Amariglio N, et al. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. J Biol Chem 2002;277:43359-68.
23. Sasaki Y, Mita H, Toyota M, et al. Identification of the interleukin 4 receptor α gene as a direct target for p73. Cancer Res 2003;63:8145-52.
24. Harms K, Nozell S, Chen X. The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci 2004;61:822-42.
25. Sasaki Y, Naishiro Y, Oshima Y, et al. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes. Oncogene 2005;24:5131-6.
26. Caserta TM, Kommagani R, Yuan Z, et al. p63 overexpression induces the expression of Sonic Hedgehog. Mol Cancer Res 2006;4:759-68.
27. Munro S. Lipid rafts: elusive or illusive? Cell 2003;115:377-88.
28. Sasaki Y, Morimoto I, Ishida S, et al. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther 2001;8:1401-8.
29. Ishida S, Yamashita T, Nakaya U, Tokino T. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Jpn J Cancer Res 2000;91:174-80.
30. Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M, El-Deiry WS. p73β, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. Int J Oncol 1998;13:5-9.
31. Stuermer CA, Lang DM, Kirsch F, et al. Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol Biol Cell 2001;12:3031-45.
32. Irwin MS, Kondo K, Marin MC, et al. Chemosensitivity linked to p73 function. Cancer Cell 2003;3:403-10.
33. Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999;399:806-9.
34. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature 1999;399:809-13.
35. Yuan ZM, Shioya H, Ishiko T, et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 1999;399:814-7.
36. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-9.
37. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992;1:45-9.
38. Maruyama R, Aoki F, Toyota M, et al. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 2006;66:4574-83.
39. Chen X, Zheng Y, Zhu J, Jiang J, Wang J. p73 is transcriptionally regulated by DNA damage, p53, and p73. Oncogene 2001;20:769-74.
40. Osada M, Park HL, Nagakawa Y, et al. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol 2005;25:6077-89.
41. Nagaich AK, Appella E, Harrington RE. DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. J Biol Chem 1997;272:14842-9.
42. Zhou H, Zhang Y, Ou-Yang Z, et al. Conformation and rigidity of DNA microcircles containing waf1 response element for p53 regulatory protein. J Mol Biol 2001;306:227-38.
43. Langhorst MF, Reuter A, Stuermer CA. Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci 2005;62:2228-40.
44. Volonte D, Galbiati F, Li S, et al. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 1999;274:12702-9.
45. Becher A, McIlhinney RA. Consequences of lipid raft association on G-protein-coupled receptor function. Biochem Soc Symp 2005;72:151-64.
46. Khoshnan A, Bae D, Tindell CA, Nel AE. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of κB factor kinase (IKK) complex plays a role in the activation of the NF-κB cascade by TCR and CD28. J Immunol 2000;165:6933-40.
47. Ostrom RS, Bundey RA, Insel PA. Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes. J Biol Chem 2004;279:19846-53.
48. Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 2006;246:91-100.
49. Dykstra ML, Cherukuri A, Pierce SK. Floating the raft hypothesis for immune receptors: access to rafts controls receptor signaling and trafficking. Traffic 2001;2:160-6.
50. Cherukuri A, Dykstra M, Pierce SK. Floating the raft hypothesis: lipid rafts play a role in immune cell activation. Immunity 2001;14:657-60.
51. Simons M, Keller P, De Strooper B, et al. Cholesterol depletion inhibits the generation of h-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 1998;95:6460-4.
52. Lafont F, Tran Van Nhieu G, Hanada K, Sansonetti P, van der Goot FG. Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J 2002;21:4449-57.
53. Manes S, del Real G, Lacalle RA, et al. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 2000;1:190-6.
54. Samuel BU, Mohandas N, Harrison T, et al. The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J Biol Chem 2001;276:29319-29.
55. Gabel BR, Elwell C, van Ijzendoorn SC, Engel JN. Lipid raft-mediated entry is not required for Chlamydia trachomatis infection of cultured epithelial cells. Infect Immun 2004;72:7367-73.
56. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1-38.
57. Aloisi F, Care A, Borsellino G, et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1h and tumor necrosis factor-α. J Immunol 1992;149:2358-66.
58. Dodd DA, Giddings TH, Jr., Kirkegaard K. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and β interferon secretion during viral infection. J Virol 2001;75:8158-65.
59. Sehgal PB, Guo GG, Shah M, Kumar V, Patel K. Cytokine signaling: STATS in plasma membrane rafts. J Biol Chem 2002;277:12067-74.
60. Morimoto I, Sasaki Y, Ishida S, Imai K, Tokino T. Identification of the osteopontin gene as a direct target of TP53. Genes Chromosomes Cancer 2002;33:270-8.